glp-1 medications for diabetes Patients Also Struggle to Access Agonists Comparing Ozempic, Wegovy and Other

GLP-1 medications like semaglutide and tirzepatide show mixed effects on gastrointestinal symptoms, with potential benefits for some IBS patients but also the risk of worsening symptoms in others

New research shows Virta is an effective off-ramp from GLP-1s for sustained weight loss

A Cox proportional hazard model was used to assess the cardiorenal protective effects between the GLP-1RA and DDP-4i groups

Discover why bariatric surgery delivers five times more weight loss than GLP-1 medications like Wegovy and Zepbound

However, many primary care clinicians hesitate to initiate basal insulin due to concerns regarding time or effort needed to educate patients, doubts about patient acceptance or ability to manage titration or injection, or patient fears of hypoglycemia

Denied Ozempic, Wegovy, or Mounjaro in Kentucky or Ohio